This Week on NeurologyLive — May 3, 2021

May 3, 2021
NeurologyLive Staff

Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!

Also this week, new episodes of the NeurologyLive Insights series, "Treating Narcolepsy and Excessive Daytime Sleepiness," featuring Phyllis C. Zee, MD, PhD, and Alon Avidan, MD, MPH, go live! So far, the pair have offered an overview of excessive daytime sleepiness and other signs and symptoms of narcolepsy, as well as some of the behavioral approaches that can be taken to the disease, and an assessment of the pharmacologic treatments and recently approved drugs to treat narcolepsy.

To catch up on the series, click here.

On Friday, be sure to check out the MJH Life Sciences Medical World News channel, as a number of new shows featuring your peers and colleagues in medicine will air! This week, on May 7, NeurologyLive will appear on the new show "Wellbeing Checkup." The show will feature Indu Subramanian, MD, director, VA Southwest Parkinson’s Disease Research, Education, and Clinical Centers, and faculty, UCLA David Geffen School of Medicine, who will offer her tips on how to stay connected with the outdoors and the importance it has for personal health.

To check out what's on the Medical World News channel now, click here.

Also on Friday, May 7, episode 36 of the NeurologyLive "Mind Moments" podcast will go live. This time, the show will feature a pair of exclusive conversations with Elyse Stock, MD, chief medical officer, Biohaven Pharmaceuticals; and Thomas Shoivitz, MD, geriatric psychiatrist, and director, California Neuroscience Research, in Sherman Oaks, California. The pair each offered their insight into the recently initiated phase 2/3 clinical trial of Biohaven's investigational calcitonin gene-related peptide antagonist, zavegepant.

To subscribe on your favorite podcast player, click here.

Throughout the week, the NeurologyLive Peer Exchange series, "Strategies for Managing Progressive Multiple Sclerosis During COVID-19," will add additional episodes. The series features a panel of individuals moderated by June Halper, MSN, MSCN, and including an expert neurologist, Mary Ann Picone, MD, who give their perspectives on the overall management of progressive multiple sclerosis and the impact of COVID-19. Thus far, they've discussed how patient appointments have been affected, and the adjustments that patients have had to make in diet and general management, among other topics.

To catch up on the series, click here.

As a reminder, the April 2021 print issue of NeurologyLive is now available on our website. Some of the feature pieces included are "Magnetic Resonance’s Impact on Diagnosis, Prognostication, and Therapeutic Approaches in Neuromuscular Disorders," by Kenneth Bender, PharmD, MA; "A Critical Evaluation of Disease-Modifying Strategies in Parkinson Disease," by Fernando L. Pagan, MD, Charbel Moussa, MBBS, PhD, and Yasar Torres-Yaghi, MD; and "Neurosurgery and Parkinson Disease: Past, Present, and Future of Deep Brain Stimulation," by Atom Sarkar, MD, PhD, among others.

To view the issue in digital form, click here.

The latest in our NeuroVoices series, dedicated to conversations with leaders in the neurology community, goes live on Wednesday, May 5. This week's features Vineet Punia, MD, MS, a neurologist from Cleveland Clinic. Punia discussed 2 pieces of research he presented at this year's American Academy of Neurology Annual Meeting, April 17-22. The first involves the efficacy, safety, and outcomes of responsive neurostimulation therapy in old adults while the second details generalized epilepsy in the elderly undergoing epilepsy monitoring unit evaluation. He broke down both studies and emphasized the need for more research involving epilepsy in elderly populations.

To check out the prior NeuroVoices conversations, click here.